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Abstract 
Ammodytin L (AMDL) is a myotoxic phospholipase-like protein from the venom of Vipera mmodytes with a serine in position 49 
instead of an aspartate, therefore this toxin is devoid of phospholipase activity, and the membrane-damaging effect does not involve any 
step of phospholipase activity. The aim of the present study was to analyze the effect of AMDL on L-6 cells from rat skeletal muscle to 
investigate its mechanism of action and the role of calcium ions in its muscle-damaging activity. Our data indicate that the effect of 
ammodytin L is strongly dependent on the degree of cell differentiation. Low doses of myotoxin gave rise to a marked release of creatine 
kinase in myotubes differentiated from L-6 myoblasts and the presence of calcium ions plays a role in the cytotoxic effect. The presence 
of EGTA in the incubation buffer reduced by 50% the release of creatine kinase. No membrane damage was observed in myoblasts, but 
there was a significant increase of intracellular calcium concentration measured with Fura-2. A non-specific membrane effect of AMDL 
was ruled out using platelets as reference cells: no platelet aggregation pattern and no increase in intracellular calcium were observed. 
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I. Introduction 
Ammodytin L (AMDL) is a myotoxic protein, compo- 
nent of the snake venom from Vipera ammodytes, which 
belongs to a class of phospholipase-like proteins, charac- 
terized by a high degree of sequence homology with 
PLA2s of class II [1,2], but differing for their enzymatic 
and pharmacological properties [3]. Recent analysis has 
revealed that AMDL possesses a serine residue instead of 
an aspartate in position 49 in the active site, the region that 
binds calcium ions [4]. 
The group of phospholipase-like myotoxins consists 
also of bothropstoxin from B. jararacussu [5], B. num- 
mifer myotoxin [6], myol:oxins I and II from B. moojeni 
[7], and B. asper myotoxin II [8,9]. The latter has been 
shown to have a lysine re~fidue in position 49 instead of an 
aspartate [9]. 
As a consequence of the substituted amino acid residue, 
Abbreviations: AMDL, ammodytin L; CK, creatine kinase; DMPC, 
dimyristoyl-phosphatidylcholine; Hepes, N-2-hydroxyethylpiperazine-N'- 
2-ethane-sulfonic a id; PLA 2, phospolipase A2; 49K, myotoxin with a 
lysine residue instead of an aspartate in position 49. 
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these proteins cannot bind Ca 2 ÷ ions in the active site, and 
are practically devoid of hydrolytic activity, i.e., am- 
modytin L has roughly 1% phospholipase activity tested 
on both DMPC liposomes and rat brain phospholipids as a 
substrate with respect o Naja naja phospholipase [10]. 
Proteins belonging to this class of phospholipase-like 
proteins show practically all myotoxic activities such as 
damage to muscular tissue in vivo [11,12]. 
Most of the studies on myotoxins have been carried out 
so far with liposomes and in vivo; few data are available 
on the effects of these toxins in cultured cells. In particu- 
lar, myotoxin II from B. asper causes a release of creatine 
and creatine kinase from muscle tissue, both in vivo and in 
vitro [13], and a release of lactic dehydrogenase from L-6 
myoblasts and mouse capillary endothelial cells [13]. 
AMDL, added one week after plating, destroys the struc- 
ture of myotubes in primary culture cells from rat skeletal 
muscle [14]. 
The advantage of cultured cells of different types for 
the study of snake toxins is now becoming evident, also 
taking into account he selective effect of rattlesnake tox- 
ins recently reported in myotubes but not in myoblasts in 
culture [ 15]. 
We have shown that both ammodytin L and myotoxin II 
can interact with the phospholipid bilayer of liposomes, 
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with a mechanism different from active PLA 2 and not 
requiring calcium ions [10,16], and these features eem to 
be a general rule for the class of PLA2-1ike myotoxins 
both in liposomes and in culture [11,12]. 
As to myotoxins with high phospholipase activity, such 
as myotoxin I and III from B. asper and myotoxins from 
B. atrox and B. godmani, the inhibition of PLA 2 activity, 
by eliminating calcium ions and adding EDTA, gives rise 
to a significant reduction of both muscle-damaging and 
liposomal-disrupting effects [11,12,17]. 
The cytopathogenic effect of myotoxin III, from B. 
asper with high phospholipase A 2 activity, was tested on 
different cell lines, and the L-6 myoblasts were found to be 
the most sensitive to this myotoxin, showing a dose-depen- 
dent release of [3H]uridine nucleotide. Surprisingly, in 
these cells a significantly reduced membrane damage was 
found in the presence of calcium ions [18]. Aim of the 
present study was to analyze the effect of AMDL, a 
phospholipase-like myotoxin from Vipera ammodytes on 
L-6 cells, from rat skeletal muscle to investigate its mecha- 
nism of action and to assess the role of calcium ions in the 
muscle-damaging activity of this myotoxin. 
L-6 cells were selected since they express many fea- 
tures of skeletal muscle, including the ability to synthesize 
muscle actin, myosin and acetylcholine receptors, and 
when they reach confluency they fuse to myotubes how- 
ing the biochemical and physiological features of muscle 
tissue: the capacity to develop action potentials and con- 
tractile responses [ 19,20]. 
Our data show that low concentrations of AMDL from 
Vipera ammodytes, in skeletal muscle cells, gave rise to a 
marked release of creatine kinase (CK) and the presence of 
Ca 2+ ions plays a role in the membrane leakage and the 
CK release. Furthermore the effect of AMDL, in skeletal 
muscle cells, is strongly dependent on the degree of cell 
differentiation. 
2. Materials and methods 
2.1. Snake venom 
AMDL from Vipera ammodytes, was purified as al- 
ready described [21] and kindly provided by Prof. F. 
Gubensek, Dept. of Biochemistry, J. Stefan Institute, 
Ljubliana, Slovenia. 
2.3. Estimation of fusion of L-6 cells 
L-6 cells were seeded and grown in DMEM supple- 
mented as reported above, in Petri dishes (35 × 10 mm) at 
the concentration of 2 • 105 cells, and a change of medium 
every 48 h. To induce the differentiation at the day of 
confluence the concentration of serum in the medium was 
reduced to 2%. The fusion index was estimated both at the 
stage of myoblasts (1 day after confluence) and myotubes 
(up to 10 days after confluence). For determination of the 
fusion index the cells were washed twice with cold phos- 
phate-buffered saline (PBS), fixed in methanol and stained 
with Wright-Giemsa. Only structures containing at least 
three nuclei were considered as myotubes, and at day 10 
after confluence the fusion index was around 60%. 
2.4. Measurements ofcreatine kinase activity 
For CK determination L-6 cells were seeded in 35 X 10 
mm dishes in DMEM medium supplememted as already 
reported, and reached confluency in approximately 5 days 
(1 • 10  6 cells/dish = 0.440 ___ 0.035 mg protein; mean + 
S.D., n = 7). Then the concentration of serum was lowered 
to 2%. Activity of CK was measured 10 days later using a 
colorimetric kit from Sigma [22]. Cell proteins were deter- 
mined according to the method of Lowry [23], using 
bovine serum albumin (BSA) as a standard. 
L-6 cells were washed with Hepes-buffered saline: N- 
2-hydroxyethylpiperazine-N'-2-ethane-sulfonic acid 
(Hepes) 20 mM, NaC1 137 mM, KCI 2.7 mM, MgC12 1 
raM, CaC12 1.5 mM and glucose 5.6 mM (pH 7.4). Cells 
were preincubated with this buffer at 37°C for 10 min, to 
equilibrate the temperature. Then the toxin was added and 
incubated for different imes or at different oxin concen- 
trations. Aliquots of 100 /xl were taken and frozen for 
subsequent CK assay. 
In all the experiments carried out in the presence of 
EGTA, the calcium was always absent from the medium. 
For the measurement of total CK cells were scraped off 
with a rubber-covered stick and resuspended in isotonic 
buffer (sucrose 250 mM, NaN 3 5 mM, EGTA 2 mM, 
Hepes 20 mM at pH 7.4), then cells were homogenized by 
a hand-driven pestle (15 strokes). The homogenate was 
then centrifuged at 700 × g for 5 min and aliquots of 100 
/zl supernatant were used for CK assay. 
2.2. Cells 
L-6 cells from rat skeletal muscle were obtained from 
American Type Culture Collection (Rockville, MD, USA). 
Cells were grown in Dulbecco's modified Eagle medium 
(DMEM), supplemented with fetal bovine serum (FBS) 
10%, streptomycin 100 /zg/ml and penicillin 100 U/ml,  
in an atmosphere of 5% CO 2 at 37°C and were kept in 
culture by continuous passages at preconfluent stages (up 
to 12). 
2.5. Human platelets 
The purification of human platelets and aggregation 
studies were carried out as described [24]. 
2.6. Measurement of intracellular calcium 
Cells grown in 25-cm 2 flasks, between days 5 and 7 
after confluence and depleted of serum as reported above, 
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were incubated for 15 min at room temperature in DMEM 
containing 1 /zM Fura-2/AM. After washing with Hepes- 
buffered saline, cells were incubated for an additional 15 
min in the same buffer supplemented with 0.1% BSA, 
gently scraped, centrifuged for 3 min at 900 × g and 
finally resuspended in Hepes-buffered saline (0.3-10 6
cells/ml). Fura-2 fluorescence, after the toxin addition, 
was followed at 37°C under continuous magnetic stirring 
in a Perkin Elmer LS-5 spectrofluorimeter at excitation 
and emission wavelengths of 340 nm and 500 nm respec- 
tively, using a slit of 5; nm for both light pathways. 
Maximum and minimum fluorescence were respectively 
determined after the addition of 0.1% Triton X-100 and 3 
mM EGTA (after the pH had been shifted to 8.5). Intra- 
cellular Ca 2 ÷ concentrations were calculated as previously 
described [25]. 
2.7. Phospholipase activity assay 
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Fig. 1. Effect of AMDL concentration  CK release from L-6 myotubes. 
CK was determined after 10 min of incubation with the toxin, as reported 
in Section 2 and is expressed in mU/mg cell protein. One mU corre- 
sponds to one nmol of creatine formed/min. Results are mean + S.D. of 5 
independent experiments carried out in duplicate. 
L-6 cells were grown in Petri dishes (35 × 10 ram) as 
already described. Five days after confluence, cells were 
labelled with 0.2 /zCi/rnl [~4C]oleic acid for 24 h. After 
medium aspiration, cells were washed twice with Hepes- 
buffered isotonic saline supplemented with BSA 0.1%. 
After 1 h of preincubation at 37 ° C, the medium was 
rapidly replaced by 1 ml of the same buffer containing 
AMDL or Naja naja PLA 2 (10/zg/ml) .  The reaction was 
blocked by aspiration of the medium, immediately fol- 
lowed by addition to the cells of cold methanol containing 
0.1 N HCI. The medium was collected, centrifuged and 
processed for the determination of the oleic acid released. 
Cells were then scraped off the substratum in methanol 
and lipid were extracted by the method of Bligh and Dyer 
[26] to determine total lipid radioactivity. In these experi- 
mental conditions radioactivity associated with the phos- 
pholipids was 270 000 _ .40 000 DPM/106 cells. 
2.8. Materials 
DMEM, antibiotics and sterile plastic ware for cell 
culture were from Flow Laboratory (Irvine, UK). FBS was 
from GIBCO (Grand Island, NY, USA). [lnc]oleic acid 
(spec. act. 52 mCi/mrnol) was from Amersham (UK). 
FURA/AM was purchased from Molecular Probes 
(Eugene, OR, USA). Creatine kinase (CK) kit, Naja naja 
PLA 2, streptolysin-O, EGTA, Hepes, and bovine serum 
albumin were from Sigma (St. Louis, MO, USA). All other 
chemicals were of the purest grade available from Merck 
(Darmstadt, Germany). 
3. Results 
Preliminary experiments carded out to assess whether 
AMDL (10 /zg/ml)  may display a phospholipase activity 
in L-6 cells did not show any detectable hydrolysis in L-6 
myotubes compared to the hydrolysis due to Naja naja 
PLA 2 (not shown). 
The total CK in myotubes was 130.33 __ 9.29 mU/mg 
cell protein, (mean _+ S.D.; n = 5). This result is in good 
agreement with previously reported ata on the same cells 
[27]. 
Fig. 1 shows the dose-response of AMDL effect on CK 
release from myotubes after 10 min. The release was 
maximal at 12 /zg/ml.  The time course of the release of 
creatine kinase from myotubes due to AMDL (8 /xg/ml) 
is shown in Fig. 2. The release reached a maximum after 
10 rain, and was approximately 50% of total CK released 
from the cell. The same graph shows also the effect of 
streptolysin-O (0.2 U/ml) ,  a protein known to cause pores 
in the plasma membrane of living cells [28]. Also in the 
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Fig. 2. Time course of the effect of AMDL on CK release in myotubes 
from L-6 cells. For CK determinations a d Unit definition see Legend to 
Fig. 1. The effect of streptolysin-O (0.2 U/ml) (l l) is shown for 
comparison to the effect of AMDL alone (8 /~g/ml) (C)) or AMDL 
together with 5 mM EGTA (O). EGTA alone did not interfere with CK 
assay. Results are mean of 5-6 independent experiments =1= S.D. carried 
out in duplicate. 
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Fig. 3. Increase of CK activity and effect of AMDL on its release during 
differentiation from myoblasts to myotubes in L-6 cells. For CK determi- 
nation and Unit definition see legend to Fig. 1. CK levels during the 
differentiation time (O) is reported as mU/mg protein, whereas the 
release due to the effect of AMDL (8 /,Lg/ml) ( • ) is reported as percent 
of total content. Results are mean of 3-4 independent experiments + S.D. 
carried out in duplicate. 
case of streptolysin-O the maximum release was achieved 
after 10 min, and was found to be close to the total content 
of CK. 
The effect of the myotoxin on CK release was also 
measured in the presence of EGTA 5 mM, in order to 
ascertain the role of extracellular Ca 2+ ions in the lytic 
effect of the myotoxin. In the presence of EGTA (5 mM) 
the release of CK due to myotoxin was about 50% the 
release found in the presence of the myotoxin only, sug- 
gesting a role of calcium ions in the effect of AMDL. 
A functional parameter of differentiation from my- 
oblasts to myotubes is the appearance and the release of 
CK activity [29], therefore we studied the release of CK in 
differentiating myoblasts up to 10 days (Fig. 3). The 
release of CK in the course of differentiation was signifi- 
cant at day 3 postconfluence, whereas the release of CK 
due to AMDL (8 /~g/mi) appeared to be significant at the 
day 5 postconfluence (P < 0.05 as assessed by a Student's 
t-test) and showed an increasing trend up to day 10. 
Since the presence of EGTA in the incubation buffer 
decreased the CK release from L-6 cells, we assessed 
whether AMDL had an effect on intracellular calcium 
levels, using the intracellular fluorescent probe Fura-2/AM 
(Fig. 4). AMDL (8 /xg/ml) gave the maximum increase of 
cytoplasmic calcium concentration. 
Our method does not allow one to distinguish the 
contribution of different cell populations (i.e., different 
degree of fusion of myoblasts) in the evaluation of intra- 
cellular calcium concentration. Therefore data reported in 
Fig. 4 should not be considered absolute values, but an 
average response of the cells to AMDL action. 
Fig. 5 is a recorder tracing of the effect of AMDL (8 
/xg/ml) on intracellular calcium concentration i  L-6 cells. 
The upper graph (Fig. 5A) shows that AMDL gave rise to 
a sustained increase of intracellular calcium concentration. 
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Fig. 4. Concentration-dependent increase of intracellular [Ca 2+ ] in L-6 
cells due to AMDL. Results are mean + S.D. of 3-5 independent experi- 
ments. 
When the extracellular calcium was blocked by EGTA (2.5 
mM), AMDL elicited a small but significant transient peak 
lasting seconds (Fig. 5B). When calcium was added again, 
AMDL gave rise to the sustained increase of intracellular 
calcium, as in the upper graph, which persisted, however, 
with a lower amplitude for l0 min. 
To assess the specificity of AMDL, we tested the effect 
of the myotoxin also on human platelets. No increase in 
intracellular calcium concentration, due to AMDL, was 
observed in platelets, suggesting a major specificity of this 
myotoxin for muscle tissue (Fig. 5C). Furthermore, low 
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Fig. 5. Time-dependent action of AMDL on [Ca 2+ ]i. (A) Effect on L-6 
cells of AMDL (8 p,g/ml); (B) effect of AMDL after EGTA (2.5 mM) 
addition and subsequent readdition of Ca 2+ ions (3 mM). Panel C shows 
the absence of AMDL (8 ~g/ml )  action in platelets (2.10 8 cells/ml). 
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doses of AMDL (8 /zg/ml) did not induce aggregation of 
human platelets and did not affect collagen-induced platelet 
aggregation ( ot shown). 
4. Discussion 
In the present paper we show, for the first time, that low 
concentrations of AMDL give rise to a dramatic release of 
CK from differentiated myotubes from L-6 cells, and the 
effect is dependent on the presence of calcium ions. 
L-6 cells have been chosen as a model for these studies 
since they have been shown to be particularly sensitive to 
the phospholipase myotoxins, compared to other cell types 
[18,30]. 
L-6 cells appear to be highly sensitive also to phospho- 
lipase-like myotoxins, in fact low concentrations of AMDL 
(8 /zg/ml) (see Fig. 1) were able to give the maximum 
release of CK. This concentration f 8 /xg/ml is approxi- 
mately 10-50 times lower as compared to 49K PLA2-1ike 
myotoxins, or to myotoxins endowed with phospholipase 
activity used by different authors [11,12,17]. The effect of 
the toxin is fast (within 10 min) and comparable to the 
effect of streptolysin-O (see Fig. 3), known to cause 
non-specific pores in the plasma membrane [28]. 
Our data on the release of CK from myotubes are in 
quite good agreement with recently reported observations 
[31] in myotubes from C2C9 cells and chick skeletal 
muscle in culture, where a great release of CK was found 
due to myotoxins from B. nummifer, devoid of phospho- 
lipase activity. 
The dependence of AMDL cytolytic effect on calcium 
ions is similar to results obtained using myotoxins with 
high phospholipase activity [12,18], but it is unexpected 
for a protein without Ca2+-dependent esterase activity. 
Since AMDL has no enzymatic activity, there is no phos- 
pholipid hydrolysis requiring calcium ions, as happens for 
myotoxic PLA 2 [ 12,18]. Therefore the presence of calcium 
must be necessary for another step of the cytolytic process. 
Calcium ions could regulate the binding of AMDL to the 
cell plasma membrane, or alternatively they could repre- 
sent the first step in cell toxicity through non-lysosomal 
protease activation [32] or cytoskeleton depolymerization 
[33,34]. We have shown that both AMDL and 49K- 
myotoxin II give rise to a sustained perturbing effect of 
artificial membranes with a process independent of cal- 
cium ions [10,16]. However, the skeletal muscle plasma 
membrane is far more complex compared to liposomes, 
and it is conceivable that ~the interaction of myotoxins with 
the muscle plasma membrane might be affected also by 
membrane components other than phospholipids, namely 
proteins and carbohydrate moieties. 
The toxic effect of non-regulated Ca 2 ÷ influx in differ- 
ent cell types is well documented [33,35] and a role for this 
ion in the cytotoxic properties of several toxins has been 
proposed [32,36,37]. In particular, the group of Gutirrrez 
postulates a role for calcium ions in myotoxicity also for 
the 49K toxins from different Bothrops nakes [6,38]. 
Alternatively, the increase of Ca 2+ found after cell 
challenge could be not toxic by itself, as described in 
different conditions [35], but it could act as a second 
messenger of more complex pathways leading to cellular 
death. It should be recalled here, that in our experimental 
conditions we can only register a variation of intracellular 
calcium, average of cell populations with a mixed degree 
of differentiation and a different sensitivity to AMDL, as 
also indicated by the release of CK (see Fig. 3). A clear 
evaluation of calcium increase due to AMDL will be 
possible only using a different experimental pproach. 
Our data on liposomes [10,16], as well as the fast 
kinetic of AMDL-induced CK leakage (see Fig. 2), leads 
to the speculation that AMDL, likewise to pore-forming 
bacterial toxins, could increase calcium influx through a 
cell plasma membrane damage (i.e., pore formation, non- 
bilayer lipid phase stabilization, etc.). Our data on platelets 
indicate that this is not the case for AMDL myotoxin: in 
fact, these cells were not affected in their aggregation 
pattern and no variation of calcium level was found after a 
toxin challenge (see Fig. 5C). On the other hand, our data 
on calcium influx in L-6 cells show that AMDL increases 
transiently intracellular calcium concentration even when 
extracellular calcium is sequestered by EGTA (see Fig. 
5B). Therefore the toxin can mobilize intracellular calcium 
stores, in a way that is likely to involve another message 
(i.e., membrane depolarization, lipid-derived second mes- 
sengers, etc.) [39]. The sustained phase of intracellular 
calcium increase could be ascribed to a well known ion 
influx activated by the release of calcium from intra- 
cellular stores (for a review on store-regulated calcium 
uptake see Ref. [40]). In any case we cannot rule out that 
other mechanisms of intracellular calcium buffering could 
be affected by the toxin, such as Ca2+-ATPase [39]. 
No cytolytic effect and no release of CK, due to 
AMDL, was found before the fusion of myoblasts to 
myotubes (before day 5 from confluency), suggesting that 
the myotoxic effect is specific for myotubes but not for 
myoblasts (see Fig. 3. In agreement with our results, a 
recent paper [15] shows that active PLA 2 rattlesnake my- 
otoxins display a cytolytic activity only in myotubes in 
culture but not in undifferentiated myoblasts. 
The group of Lazdunski in the last few years has 
reported the presence in isolated muscle cells and in 
neuronal membranes of specific receptors for the active 
PLA 2 of the snake Oxyuranus cutellatus . [41,42]. The 
muscle receptors are pharmacologically and structurally 
different from those found in neuronal membranes. Fur- 
thermore, the muscle receptors increase during in vitro cell 
differentiation from myoblasts to myotubes [42]. 
Different PLA 2 receptors are present in different tissues 
indicating the specificity of PLA 2 actions. On the other 
hand, the expression of receptor number, enzymes or ionic 
channels in muscle cells is often in close relation with the 
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differentiation state of the cells. The poor knowledge on 
PLA 2-like myotoxins' cellular effects and specificity does 
not allow much speculation, but the hypothesis of the 
presence of a specific receptor also for the PLA2-1ike 
myotoxins appears to be quite appealing. Research is in 
progress in our laboratory to assess whether this interesting 
model could apply also to PLA2-1ike myotoxins. 
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